Involvement of dual-strand of the miR-144 duplex and their targets in the pathogenesis of lung squamous cell carcinoma

NCS-1 is a regulator of calcium signaling in health and disease

(2018) Göran R. Boeckel et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH

Regulation of anti-tumor miR-144-5p targets oncogenes: direct regulation of syndecan-3 and its clinical significance

(2018) Yasutaka Yamada et al.   CANCER SCIENCE

Osimertinib in Untreated EGFR-Mutated Advanced Non–Small-Cell Lung Cancer

(2018) Jean-Charles Soria et al.   NEW ENGLAND JOURNAL OF MEDICINE

Dual strands of the miR-145 duplex (miR-145-5p and miR-145-3p) regulate oncogenes in lung adenocarcinoma pathogenesis

(2018) Shunsuke Misono et al.   JOURNAL OF HUMAN GENETICS

TUG1 promotes osteosarcoma tumorigenesis by upregulating EZH2 expression via miR-144-3p

(2017) Jiaqing Cao et al.   INTERNATIONAL JOURNAL OF ONCOLOGY

The microRNA expression signature of small cell lung cancer: tumor suppressors of miR-27a-5p and miR-34b-3p and their targeted oncogenes

(2017) Keiko Mizuno et al.   JOURNAL OF HUMAN GENETICS

Calcium Sensor, NCS-1, Promotes Tumor Aggressiveness and Predicts Patient Survival

(2017) Lauren M. Moore et al.   MOLECULAR CANCER RESEARCH

Alectinib versus Crizotinib in Untreated ALK-Positive Non–Small-Cell Lung Cancer

(2017) Solange Peters et al.   NEW ENGLAND JOURNAL OF MEDICINE

MicroRNA-144-3p suppresses tumor growth and angiogenesis by targeting SGK3 in hepatocellular carcinoma

(2017) Manya Wu et al.   ONCOLOGY REPORTS

Deep sequencing-based microRNA expression signatures in head and neck squamous cell carcinoma: dual strands of pre-miR-150 as antitumor miRNAs

(2017) Keiichi Koshizuka et al.   Oncotarget

The microRNA expression signature of pancreatic ductal adenocarcinoma by RNA sequencing: anti-tumour functions of the microRNA-216 cluster

(2017) Keiichi Yonemori et al.   Oncotarget

Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015

(2017) et al.   JAMA Oncology

Regulation of TPD52 by antitumor microRNA-218 suppresses cancer cell migration and invasion in lung squamous cell carcinoma

(2016) Tomohiro Kumamoto et al.   INTERNATIONAL JOURNAL OF ONCOLOGY

The microRNA signatures: aberrantly expressed microRNAs in head and neck squamous cell carcinoma

(2016) Keiichi Koshizuka et al.   JOURNAL OF HUMAN GENETICS

MicroRNAs in non-small cell lung cancer and idiopathic pulmonary fibrosis

(2016) Keiko Mizuno et al.   JOURNAL OF HUMAN GENETICS

Regulatory mechanisms of microRNA expression

(2016) Lyudmila F. Gulyaeva et al.   Journal of Translational Medicine

Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer

(2016) Martin Reck et al.   NEW ENGLAND JOURNAL OF MEDICINE

Correlation between serum IL-1β and miR-144-3p as well as their prognostic values in LUAD and LUSC patients

(2016) Chen Wu et al.   Oncotarget

Dual-strand tumor-suppressor microRNA-145 (miR-145-5p and miR-145-3p) coordinately targeted MTDH in lung squamous cell carcinoma

(2016) Hiroko Mataki et al.   Oncotarget

Final overall survival results from a randomised, phase III study of erlotinib versus chemotherapy as first-line treatment of EGFR mutation-positive advanced non-small-cell lung cancer (OPTIMAL, CTONG-0802)

(2015) C. Zhou et al.   ANNALS OF ONCOLOGY

Sense and specificity in neuronal calcium signalling

(2015) Robert D. Burgoyne et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH

Tumour-suppressive microRNA-144-5p directly targets CCNE1/2 as potential prognostic markers in bladder cancer

(2015) R Matsushita et al.   BRITISH JOURNAL OF CANCER

Tumor-suppressive microRNA-29 family inhibits cancer cell migration and invasion directly targeting LOXL2 in lung squamous cell carcinoma

(2015) KEIKO MIZUNO et al.   INTERNATIONAL JOURNAL OF ONCOLOGY

miR-144-3p exerts anti-tumor effects in glioblastoma by targeting c-Met

(2015) Fengming Lan et al.   JOURNAL OF NEUROCHEMISTRY

MARCKS Is Marked in Combating Lung Cancer Growth and Acquired Resistance

(2014) Sekhar P. Reddy et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Targeting Myristoylated Alanine-Rich C Kinase Substrate Phosphorylation Site Domain in Lung Cancer. Mechanisms and Therapeutic Implications

(2014) Ching-Hsien Chen et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Tumor-suppressive microRNA-206 as a dual inhibitor of MET and EGFR oncogenic signaling in lung squamous cell carcinoma

(2014) HIROKO MATAKI et al.   INTERNATIONAL JOURNAL OF ONCOLOGY

Downregulation of the microRNA-1/133a cluster enhances cancer cell migration and invasion in lung-squamous cell carcinoma via regulation of Coronin1C

(2014) Hiroko Mataki et al.   JOURNAL OF HUMAN GENETICS

Dopamine D2 receptor agonists inhibit lung cancer progression by reducing angiogenesis and tumor infiltrating myeloid derived suppressor cells

(2014) Luke H. Hoeppner et al.   Molecular Oncology

Genome-Wide Epigenetic Regulation of miRNAs in Cancer

(2013) C. Baer et al.   CANCER RESEARCH

Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal

(2013) J. Gao et al.   Science Signaling

Tumour suppressors miR-1 and miR-133a target the oncogenic function of purine nucleoside phosphorylase (PNP) in prostate cancer

(2011) S Kojima et al.   BRITISH JOURNAL OF CANCER

Pathology of Lung Cancer

(2011) William D. Travis   CLINICS IN CHEST MEDICINE

MicroRNAs: Target Recognition and Regulatory Functions

(2009) David P. Bartel   CELL

Retrospective Evaluation of the Clinical and Radiographic Risk Factors Associated With Severe Pulmonary Hemorrhage in First-Line Advanced, Unresectable Non–Small-Cell Lung Cancer Treated With Carboplatin and Paclitaxel Plus Bevacizumab

(2009) Alan B. Sandler et al.   JOURNAL OF CLINICAL ONCOLOGY